Hvad betyder "Ryd"?
Dyret bærer ikke mutationen. Det vil ikke udvikle sygdommen og vil ikke give det videre.
Cerebellar Ataxia in Finnish Hound (CA-FH) is a genetic condition that affects the coordination and movement of these beloved dogs. A DNA test for CA-FH can help breeders and owners identify carriers of the gene, ensuring healthier breeding practices. Early detection through genetic testing allows for informed decisions, potentially reducing the incidence of this debilitating disorder. By understanding the risks associated with Cerebellar Ataxia, owners can provide better care and support for their Finnish Hounds. Investing in a CA-FH DNA test not only protects your pet's health but also contributes to the overall well-being of the breed. Discover peace of mind and promote responsible breeding with this essential genetic test. Ensure your Finnish Hound thrives with the knowledge gained from CA-FH testing today!
Cerebellar Ataxia in Finnish Hound (CA-FH) is a genetic disorder that affects the coordination and balance in dogs. This condition is caused by mutations in the gene responsible for proper cerebellar function. A DNA test for CA-FH can help identify carriers and affected individuals, allowing breeders to make informed decisions. Early detection through testing can improve the quality of life for affected dogs and reduce the prevalence of the disorder in future generations. Responsible breeding practices are essential to ensure the health and well-being of Finnish Hounds.
Denne DNA-test er inkluderet fra vores pakke Basic — og er også en del af pakkerne Basic, Standard, Advanced, Complete.
Se DNA-testpakker →Cerebellar Ataxia in Finnish Hound (CA-FH) is a hereditary neurological disorder that affects the coordination and balance of dogs. This condition arises from a genetic mutation that impacts the cerebellum, a part of the brain responsible for motor control. As a result, dogs suffering from CA-FH exhibit difficulty in movement, leading to uncoordinated actions and an increased risk of falls.
The symptoms of CA-FH typically manifest in the early stages of a dog's life, usually between six months to two years. Affected dogs may display a range of symptoms, including unsteady gait, difficulty in precise movements, and abnormal body posture. They may also show signs of tremors, particularly in their limbs, and experience challenges with tasks that require fine motor skills, such as fetching or jumping. In severe cases, dogs may exhibit head bobbing and an inability to perform basic tasks.
Although dogs with CA-FH can lead relatively normal lives, the condition can significantly affect their overall quality of life. The lack of coordination can make everyday activities challenging, and owners may need to provide additional support and supervision. While there is no cure for CA-FH, many affected dogs can adapt to their condition with proper care and management.
DNA testing plays a crucial role in diagnosing Cerebellar Ataxia in Finnish Hound. The test identifies the presence of the specific genetic mutation associated with the disorder. A positive result confirms that the dog is affected by CA-FH, while a negative result can provide reassurance to breeders and owners regarding the dog’s genetic health. This testing is essential in breeding programs to prevent the propagation of the disorder in future generations.
While there is no treatment to cure CA-FH, supportive care can help manage the symptoms and improve the quality of life for affected dogs. This may include physical therapy to enhance mobility and strength, as well as environmental modifications to ensure safety. Owners should provide a safe and stable environment, avoiding situations that might lead to falls or injuries. Regular veterinary check-ups are also important to monitor the dog's health and adjust care as needed.
Cerebellar Ataxia in Finnish Hound is a significant genetic condition that requires attention from both breeders and owners. Understanding the symptoms, diagnosis, and management strategies is essential in providing the best care for affected dogs. DNA testing is a valuable tool in identifying carriers and affected individuals, ensuring informed breeding practices and improving the health of future generations.
Dyret bærer ikke mutationen. Det vil ikke udvikle sygdommen og vil ikke give det videre.
Nej. Dyret er generelt sundt, men kan overføre mutationen til dens afkom.
Den bærer to muterede kopier. Kliniske tegn forventes afhængig af sygdommen. Det skal ikke avles.
Nogle sygdomme er kønsbundne, så deres udtryk varierer afhængigt af dyrs køn.
This DNA test detects the mutation associated with Cerebellar Ataxia In Finnish Hound (CA) in order to identify clear, carrier, or at-risk animals.
DNA-test hjælper opdrættere med at planlægge sikrere parringer og reducerer risikoen for at overføre mutationen til afkom.
Den nedarvede tilstand, der er rapporteret for denne test, er autosomal recessiv.
This test analyses the mutation SEL1L c.1972T>C.
Ikke nødvendigvis. Fortolkningen afhænger af arvemønsteret og den resulterende genotype.
Kyöstilä Kaisa, Cizinauskas Sigitas, Seppälä Eija H, Suhonen Esko, Jeserevics Janis, Sukura Antti, Syrjä Pernilla, Lohi Hannes. A SEL1L mutation links a canine progressive early-onset cerebellar ataxia to the endoplasmic reticulum-associated protein degradation (ERAD) machinery. PLoS Genet. 2012;8(6):e1002759. doi: 10.1371/journal.pgen.1002759. Epub 2012 Jun 14.
Din privatliv, dit valg
Vi bruger vigtige cookies til at drive hjemmesiden. Valgfrie cookies (såsom udbydere af integreret indhold) er deaktiveret som standard og er kun aktiveret, hvis du er enig. Du kan til enhver tid ændre dit valg ved at bruge knappen "Cookies".
Nødvendig for kernefunktioner og sikkerhed. Altid aktiveret.
Forbedrer funktioner som præferencegemning eller ikke-reklameindhold.
Hjælper os med at forstå brugen af siden. Deaktiveret som standard.
Reklame/sporing på tværs af sider (nogle video/kort indlejrede). Deaktiveret som standard.